Timolol/Pilocarpine Hydrochloride

噻吗洛尔/盐酸毛果芸香碱

Report date: 2022/01/19 18:02:08

Base Information

Drug NameTimolol/Pilocarpine Hydrochloride
Drug Alias Name复方噻吗洛尔滴眼液
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonistsMuscarinic acetylcholine receptor agonists
TargetsBeta adrenergic receptorsMuscarinic acetylcholine receptor
Therapy Area/IndicationsGlaucomaOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A